Decatris MP - Search Results

1

Reversibility of liver failure secondary to metastatic breast cancer by vinorelbine and cisplatin chemotherapy.

Sharma RA, Decatris MP, Santhanam S, Roy R, Osman AE, Clarke CB, Khanna S, O'Byrne KJ. Sharma RA, et al. Among authors: decatris mp. Cancer Chemother Pharmacol. 2003 Nov;52(5):367-70. doi: 10.1007/s00280-003-0679-8. Epub 2003 Jul 18. Cancer Chemother Pharmacol. 2003. PMID: 12879281 Clinical Trial.

2

A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer.

O'Byrne KJ, Thomas AL, Sharma RA, DeCatris M, Shields F, Beare S, Steward WP. O'Byrne KJ, et al. Br J Cancer. 2002 Jul 1;87(1):15-20. doi: 10.1038/sj.bjc.6600344. Br J Cancer. 2002. PMID: 12085249 Free PMC article. Clinical Trial.

3

Potential of interferon-alpha in solid tumours: part 1.

Decatris M, Santhanam S, O'Byrne K. Decatris M, et al. BioDrugs. 2002;16(4):261-81. doi: 10.2165/00063030-200216040-00003. BioDrugs. 2002. PMID: 12196039 Review.

4

Potential of interferon-alpha in solid tumours: part 2.

Santhanam S, Decatris M, O'Byrne K. Santhanam S, et al. BioDrugs. 2002;16(5):349-72. doi: 10.2165/00063030-200216050-00004. BioDrugs. 2002. PMID: 12408739 Review.

5

Platinum-based chemotherapy in metastatic breast cancer: current status.

Decatris MP, Sundar S, O'Byrne KJ. Decatris MP, et al. Cancer Treat Rev. 2004 Feb;30(1):53-81. doi: 10.1016/S0305-7372(03)00139-7. Cancer Treat Rev. 2004. PMID: 14766126 Review.

6

Management of endocrine resistant breast cancer.

Sundar S, Decatris MP, O'Byrne KJ. Sundar S, et al. Among authors: decatris mp. J Br Menopause Soc. 2004 Mar;10(1):16-23. doi: 10.1258/136218004322986735. J Br Menopause Soc. 2004. PMID: 15107207 Review.

7

Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy.

Sundar S, Symonds RP, Decatris MP, Kumar DM, Osman A, Vasanthan S, O'byrne KJ. Sundar S, et al. Among authors: decatris mp. Gynecol Oncol. 2004 Aug;94(2):502-8. doi: 10.1016/j.ygyno.2004.04.020. Gynecol Oncol. 2004. PMID: 15297195 Clinical Trial.

8

Endothelin-1 is a novel prognostic factor in non-small cell lung cancer.

Arun C, DeCatris M, Hemingway DM, London NJ, O'Byrne KJ. Arun C, et al. Int J Biol Markers. 2004 Oct-Dec;19(4):262-7. doi: 10.1177/172460080401900402. Int J Biol Markers. 2004. PMID: 15646831 Free article.

9

Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience.

Decatris MP, Sundar S, O'Byrne KJ. Decatris MP, et al. Clin Oncol (R Coll Radiol). 2005 Jun;17(4):249-57. doi: 10.1016/j.clon.2005.04.001. Clin Oncol (R Coll Radiol). 2005. PMID: 15997920

10

Clinician Perspective on Molecular Profiling of Non-Small-Cell Lung Cancer.

Decatris MP, Farrugia D, O'Byrne KJ. Decatris MP, et al. J Clin Oncol. 2016 Mar 10;34(8):884-6. doi: 10.1200/JCO.2015.65.2040. Epub 2016 Jan 11. J Clin Oncol. 2016. PMID: 26755521 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters